Imaging PVR: Comparative Accuracy of Noninvasive Techniques

Imaging PVR for Treatment Planning: Pre- and Post-Intervention Assessment

Overview

Imaging of pulmonary vascular resistance (PVR) and pulmonary vascular remodeling—commonly abbreviated in practice contexts as “Imaging PVR” when referring to imaging studies used to assess pulmonary vascular disease—supports treatment planning by characterizing anatomy, hemodynamics, and tissue changes before intervention and by documenting response afterward.

Pre-intervention assessment

• Goals: quantify disease severity, localize lesions, evaluate surgical/interventional candidacy, and plan device sizing or surgical approach.
• Primary modalities:
  • CT pulmonary angiography (CTPA): high-resolution depiction of pulmonary arteries, thromboembolic burden, stenoses, and collateral vessels. Useful for procedural planning (stent/balloon sizing, endarterectomy mapping).
  • Cardiac MRI (CMR): phase-contrast MRI measures pulmonary artery flow, stroke volume, and right ventricular (RV) volumes/function; sequence-based flow quantification can estimate pulmonary flow distribution and help infer pulmonary vascular load.
  • Echocardiography (transthoracic/transesophageal): RV size/function, estimation of pulmonary artery systolic pressure, valve function, and detection of shunts. Portable and first-line for screening and hemodynamic clues.
  • Nuclear imaging (V/Q scan): crucial when chronic thromboembolic disease is suspected; identifies perfusion defects guiding revascularization decisions.
  • Invasive right heart catheterization with selective pulmonary angiography: gold standard for direct PVR measurement (via pressure and cardiac output) and definitive angiographic mapping before interventions.
• Key measurements and findings to report:
  • RV size and ejection fraction
  • Pulmonary artery diameters and prominent branch stenoses/occlusions
  • Regional perfusion defects and collateralization
  • Quantitative flow (ml/beat, peak velocities) and estimated PVR when noninvasive flow + pressure data available
  • Presence of organized thrombus, webbing, or vascular remodeling
• How imaging informs planning: selects candidates for thromboendarterectomy vs. balloon pulmonary angioplasty, guides catheter access and device selection, anticipates complications (e.g., reperfusion edema), and estimates procedural risk based on RV function.

Intra- and immediate post-intervention imaging

• Intra-procedural fluoroscopic angiography: real-time assessment of lesion crossing, immediate vessel patency, and detection of extravasation.
• Immediate post-op imaging: chest radiograph for complications (effusion, edema); selective angiography or limited CT if technical concerns.

Follow-up and longer-term post-intervention assessment

• Goals: document technical success, quantify hemodynamic improvement, monitor for restenosis or residual disease, and assess RV reverse remodeling.
• Timing: typical early follow-up at 24–72 hours for acute complications; 3–6 months for functional/hemodynamic reassessment; annual imaging thereafter as indicated.
• Modalities and roles:
  • Echocardiography: serial RV function and estimated pressures; accessible for routine follow-up.
  • CMR: gold standard for RV volumes/function and noninvasive flow quantification to document reverse remodeling and changes in stroke volume and cardiac output.
  • CTPA / angiography: detect residual stenosis, vessel remodeling, and guide repeat interventions if needed.
  • V/Q scanning: monitor perfusion improvement after revascularization in chronic thromboembolic disease.
  • Right heart catheterization: repeat when clinical or imaging discordance occurs or to guide further therapy—provides direct PVR measurement.
• Key post-intervention metrics: reduction in mean pulmonary artery pressure, decrease in calculated PVR, improvement in RV ejection fraction and dimensions, improved regional perfusion on V/Q or perfusion CT.

Reporting checklist for treatment planning and follow-up

• Pre-intervention: RV size/function, pulmonary artery pressures (if available), lesion location/type, perfusion defects, degree of stenosis/occlusion, thrombus characterization, collateral vessels, recommended access/approach.
• Post-intervention: technical success (patency/angiographic result), complications, changes in RV metrics, changes in perfusion, recommendation for further imaging or catheterization.

Practical considerations

• Combine modalities: use complementary strengths (V/Q for perfusion, CTPA for anatomy, CMR for RV function and flow, catheterization for definitive hemodynamics).
• Coordinate timing of invasive and noninvasive studies to provide actionable data for procedural teams.
• Document quantitative baseline values to enable objective assessment of treatment effect.

If you want, I can draft a one-page imaging protocol template (modalities, sequences, measurements, and reporting fields) tailored for pulmonary endarterectomy or balloon pulmonary angioplasty.